A separate study also demonstrated alternative inhibitory mechanisms, such as IL-17 stimulation of intratumoral neutrophil infiltration, as contributors to PD-1 blockade resistance by lung cancer [34]. This evidence concerns the gene PDCD1 and lung cancer.